Webinar Information

Webinar Description

Immunotherapy has become integrated into therapy for many solid tumors. As this new modality has evolved through recurrent/metastatic and recently into the locally advanced setting, new insights and dangers have been encountered, providing insights into complex interactions of conventional modalities with immunotherapeutic modulation of the tumor microenvironment and clinical benefit for patients. The roles of treatment intensification and de-intensification using immunotherapy will be discussed.

Learning Objectives

• Understand the current status of approved immunotherapeutic agents in HNSCC
• Recognize the impact of immunotherapy on the tumor microenvironment in treated tumors including the interaction with conventional oncologic therapies
• Learn the potential roles of treatment intensification and de-intensification using immunotherapy in locally advanced HNSCC

Webinar Registration

Take Course

You must have an account and be logged in to register for and to access the course.

Please contact us with any questions at [email protected] or (919) 445–1000.